MUCOSAL EOSINOPHILS AS MARKERS OF POST- INDUCTION VEDOLIZUMAB RESPONSE IN PAEDIATRIC ULCERATIVE COLITIS

被引：0
|
作者：
Musto, F. [1 ]
Ranalli, M. [1 ]
Giordano, C. [1 ]
Bianchi, E. [1 ]
Veraldi, S. [1 ]
Oliva, S. [1 ]
D'Arcangelo, G. [1 ]
Aloi, M. [1 ]
机构：
[1] Sapienza Univ, Rome, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2023年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OC.14.5
引用
收藏
页码：S126 / S126
页数：1
相关论文
共 50 条
  • [1] Mucosal eosinophils as markers of post-induction vedolizumab response in paediatric Ulcerative Colitis
    Musto, F.
    Ranalli, M.
    Giordano, C.
    Bianchi, E.
    Veraldi, S.
    Oliva, S.
    D'Arcangelo, G.
    Aloi, M.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 752 - 753
  • [2] EXTENT OF MUCOSAL INFLAMMATION IN ULCERATIVE COLITIS INFLUENCES THE CLINICAL RESPONSE TO VEDOLIZUMAB
    Scarozza, P.
    Laudisi, F.
    Troncone, E.
    Marafini, I.
    Schmitt, H.
    Lenti, M. V.
    Costa, S.
    Rocchetti, I.
    De Cristofaro, E.
    Salvatori, S.
    Frezzati, L.
    Di Sabatino, A.
    Atreya, R.
    Neurath, M. F.
    Monteleone, G.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : S38 - S39
  • [3] Vedolizumab for induction and maintenance of remission in ulcerative colitis
    Bickston, Stephen J.
    Behm, Brian W.
    Tsoulis, David J.
    Cheng, Jianfeng
    MacDonald, John K.
    Khanna, Reena
    Feagan, Brian G.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (08):
  • [4] Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
    Feagan, Brian G.
    Rutgeerts, Paul
    Sands, Bruce E.
    Hanauer, Stephen
    Colombel, Jean-Frederic
    Sandborn, William J.
    Van Assche, Gert
    Axler, Jeffrey
    Kim, Hyo-Jong
    Danese, Silvio
    Fox, Irving
    Milch, Catherine
    Sankoh, Serap
    Wyant, Tim
    Xu, Jing
    Parikh, Asit
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (08): : 699 - 710
  • [5] Reduction of mucosal (active) eosinophils, B cells and T cells after vedolizumab therapy in patients with ulcerative colitis
    Jacobs, I.
    Cremer, J.
    Ferrante, M.
    Sabino, J.
    Vermeire, S.
    Breynaert, C.
    Vanuytsel, T.
    Verstockt, B.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I262 - I263
  • [6] Mucosal Eosinophilia is an Independent Predictor of Vedolizumab Effectiveness in Ulcerative Colitis
    Gremida, A.
    Huang, K.
    Ciorba, M.
    Deyali, C.
    Deepak, P.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S537 - S537
  • [7] Exposure-response relationship during vedolizumab induction therapy in adults with ulcerative colitis
    Rosario, M.
    French, J.
    Dirks, N.
    Milton, A.
    Fox, I.
    Gastonguay, M.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S270 - S271
  • [8] Mucosal α4β7+Lymphocytes and MAdCAM plus Venules Predict Response to Vedolizumab in Ulcerative Colitis
    Roosenboom, Britt
    Wahab, Peter J.
    Smids, Carolijn
    Meijer, Jos
    Kemperman, Larissa G. J. M.
    Groenen, Marcel J. M.
    van Lochem, Ellen G.
    Horje, Carmen S. Horjus Talabur
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (06) : 930 - 938
  • [9] Extent of Mucosal Inflammation in Ulcerative Colitis Influences the Clinical Remission Induced by Vedolizumab
    Scarozza, Patrizio
    Marafini, Irene
    Laudisi, Federica
    Troncone, Edoardo
    Schmitt, Heike
    Lenti, Marco Vincenzo
    Costa, Stefania
    Rocchetti, Irene
    De Cristofaro, Elena
    Salvatori, Silvia
    Frezzati, Ludovica
    Di Sabatino, Antonio
    Atreya, Raja
    Neurath, Markus F.
    Calabrese, Emma
    Monteleone, Giovanni
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (02)
  • [10] Identifying predictive signalling networks for Vedolizumab response in ulcerative colitis
    Amrinder Singh
    Christopher G. Fenton
    Endre Anderssen
    Ruth H. Paulssen
    International Journal of Colorectal Disease, 2022, 37 : 1321 - 1333
12345